Researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, in collaboration with scientists at Jumpcode Genomics, have developed a next generation sequencing (NGS) workflow that could help transform the future of large-scale pandemic responses and focused clinical infectious disease testing. The NGS workflow can enable earlier detection and responses to pathogen outbreaks , variant strain typing, co-infection detection and individual human host response assessment. The workflow is pathogen agnostic and could potentially inform pandemic preparedness plans in the future.
Tag: Nicholas Schork
TGen study allows late-stage cancer patients to use their health data to guide care
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.